Literature DB >> 19929695

Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results.

Subash Babu1, Sajid Q Bhat, N Pavan Kumar, V Kumaraswami, Thomas B Nutman.   

Abstract

BACKGROUND: The factors governing latency in tuberculosis are not well understood but appear to involve both the pathogen and the host. We have used tuberculin skin test (TST) positivity as a tool to study cytokine responses in latent tuberculosis.
METHODS: To identify the host factors that are important in the maintenance of TST positivity, we examined mycobacteria-specific immune responses of TST-positive (latent tuberculosis) or TST-negative individuals in South India, where TST positivity can define tuberculosis latency.
RESULTS: Although purified protein derivative-specific and Mycobacterium tuberculosis culture filtrate antigen-specific Th1 and Th2 cytokines were not statistically significantly different between the 2 groups, the Th17 cytokines (interleukin 17 and interleukin 23) were statistically significantly decreased in TST-positive individuals, compared with those in TST-negative individuals. This Th17 cytokine modulation was associated with statistically significantly increased expression of cytotoxic T lymphocyte antigen 4 (CTLA-4) and Foxp3. Although CTLA-4 blockade failed to restore full production of interleukin 17 and interleukin 23 in TST-positive individuals, depletion of regulatory T cells significantly increased production of these cytokines.
CONCLUSION: TST positivity is characterized by increased activity of regulatory T cells and a coincident down-regulation of the Th17 response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19929695      PMCID: PMC2791194          DOI: 10.1086/648735

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection.

Authors:  Troels Lillebaek; Asger Dirksen; Inga Baess; Benedicte Strunge; Vibeke Ø Thomsen; Ase B Andersen
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

Review 2.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 3.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

Review 4.  Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.

Authors:  Ming O Li; Richard A Flavell
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

5.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

Review 6.  Lessons from experimental Mycobacterium tuberculosis infections.

Authors:  JoAnne L Flynn
Journal:  Microbes Infect       Date:  2006-01-18       Impact factor: 2.700

7.  IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB.

Authors:  Virginia Pasquinelli; James C Townsend; Javier O Jurado; Ivana B Alvarez; María F Quiroga; Peter F Barnes; Buka Samten; Verónica E García
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

8.  Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.

Authors:  Paul Vinton; Seema Mihrshahi; Paul Johnson; Grant A Jenkin; Damien Jolley; Beverley-Ann Biggs
Journal:  Infect Control Hosp Epidemiol       Date:  2009-03       Impact factor: 3.254

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Persistence of the immune response induced by BCG vaccination.

Authors:  Rosemary E Weir; Patricia Gorak-Stolinska; Sian Floyd; Maeve K Lalor; Sally Stenson; Keith Branson; Rose Blitz; Anne Ben-Smith; Paul E M Fine; Hazel M Dockrell
Journal:  BMC Infect Dis       Date:  2008-01-25       Impact factor: 3.090

View more
  22 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions.

Authors:  Danillo Lucas Alves Espósito; Valdes Roberto Bollela; Ana Luisa Pereira Feitosa; Benedito Antonio Lopes da Fonseca
Journal:  Lung       Date:  2015-09-25       Impact factor: 2.584

5.  Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.

Authors:  Kristin L Griffiths; Ansar A Pathan; Angela M Minassian; Clare R Sander; Natalie E R Beveridge; Adrian V S Hill; Helen A Fletcher; Helen McShane
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

6.  Multifunctional CD4 T cell responses in patients with active tuberculosis.

Authors:  Zhengang Qiu; Mingxia Zhang; Yuzhen Zhu; Feiqun Zheng; Puxuan Lu; Haiying Liu; Michael W Graner; Boping Zhou; Xinchun Chen
Journal:  Sci Rep       Date:  2012-01-10       Impact factor: 4.379

7.  IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.

Authors:  Emmanuel Stephen-Victor; Varun Kumar Sharma; Mrinmoy Das; Anupama Karnam; Chaitrali Saha; Maxime Lecerf; Caroline Galeotti; Srinivas V Kaveri; Jagadeesh Bayry
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

Review 8.  Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers.

Authors:  I V Lyadova; A V Panteleev
Journal:  Mediators Inflamm       Date:  2015-11-10       Impact factor: 4.711

9.  The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients.

Authors:  Bruna Daniella Souza Silva; Daniela Graner Schuwartz Tannus-Silva; Marcelo Fouad Rabahi; Andre Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-02       Impact factor: 2.743

10.  Comparative immune responses against Psoroptes ovis in two cattle breeds with different susceptibility to mange.

Authors:  Charlotte Sarre; Ana González-Hernández; Stefanie Van Coppernolle; Rika Grit; Korneel Grauwet; Frederik Van Meulder; Koen Chiers; Wim Van den Broeck; Peter Geldhof; Edwin Claerebout
Journal:  Vet Res       Date:  2015-11-19       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.